“To strive to develop the highest standards of clinical care of hospitalized patients with skin disease by promoting clinical expertise, fostering research, and furthering education in the management of hospitalized patients with cutaneous disease.”
Upcoming Meetings:
SDH Annual Meeting in association with the 2020 AAD
Friday, March 20th, 2020, 5:30 PM to 8:30 PM
Sheraton Denver Downtown, Silver Room Denver, CO
Agenda
| 5:15 – 5:30 PM | Check in, Welcome/Refreshments | |
| 5:35 PM | Business Meeting | Lindy Fox, MD |
| 5:45 PM | Bedside Diagnostic Tests | Kari Wanat, MD |
| 6:20 PM | Oral Abstract Session | Joanna Harp MD, Moderator |
| 6:25 – 6:35PM | Increased risk of mortality from SJS/TEN among black patients in Washington, D.C. | Adam Swigost, MD |
| 6:35 – 6:45PM | The use of teledermatology by dermatology hospitalists is effective in diagnosis and management of inpatient disease | Colleen Gabel, BS |
| 6:45 – 6:55PM | A cross-sectional study of QOL, psychological impact, and end organ damage in survivors of severe drug eruptions | Melissa Hoffman, MS |
| 7:05 – 7:15PM | Prognostic implications of normal or minimal urinary findings on long-term renal impairment in adults with HSP | Brad Rumancik, PharmD |
| 7:15 – 7:25PM | The Koebner phenomenon in calciphylaxis | Colleen Gabel, BS |
| 7:25 – 7:35PM | Comprehensive genomic analysis of severe cutaneous drug reactions | Thomas Beachkofsky, MD |
| 7:35PM | Task Force Review, Scientific Task Force Report, Research Collaboration Updates | Alex Ortega MD
Robert Micheletti MD Lucia Seminario Vidal MD |
8:20PM Wrap up and Adjourn
